Similarly, the genetic variants in Tp53 do not show effect on the risk of breast cancer [22], suggesting that any effect of genetic variants in Tp53 or FATS on breast cancer would be very small or possibly confined to subgroups. This evidence concerns the gene TP53 and breast carcinoma.